SBRA vs. TXG
Compare and contrast key facts about Sabra Health Care REIT, Inc. (SBRA) and 10x Genomics, Inc. (TXG).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBRA or TXG.
Key characteristics
| SBRA | TXG | |
|---|---|---|
| YTD Return | 46.59% | -71.59% |
| 1Y Return | 51.07% | -55.19% |
| 3Y Return (Ann) | 20.42% | -54.49% |
| 5Y Return (Ann) | 5.80% | -23.63% |
| Sharpe Ratio | 2.60 | -0.88 |
| Sortino Ratio | 3.39 | -1.26 |
| Omega Ratio | 1.42 | 0.84 |
| Calmar Ratio | 2.30 | -0.61 |
| Martin Ratio | 14.60 | -1.12 |
| Ulcer Index | 3.88% | 50.56% |
| Daily Std Dev | 21.53% | 64.53% |
| Max Drawdown | -74.93% | -92.66% |
| Current Drawdown | 0.00% | -92.14% |
Fundamentals
| SBRA | TXG | |
|---|---|---|
| Market Cap | $4.65B | $1.92B |
| EPS | $0.41 | -$1.52 |
| Total Revenue (TTM) | $609.66M | $629.74M |
| Gross Profit (TTM) | $275.08M | $414.92M |
| EBITDA (TTM) | $400.44M | -$126.33M |
Correlation
The correlation between SBRA and TXG is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SBRA vs. TXG - Performance Comparison
In the year-to-date period, SBRA achieves a 46.59% return, which is significantly higher than TXG's -71.59% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SBRA vs. TXG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sabra Health Care REIT, Inc. (SBRA) and 10x Genomics, Inc. (TXG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SBRA vs. TXG - Dividend Comparison
SBRA's dividend yield for the trailing twelve months is around 6.10%, while TXG has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBRA Sabra Health Care REIT, Inc. | 6.10% | 8.41% | 9.65% | 8.86% | 7.77% | 8.43% | 10.92% | 9.22% | 6.84% | 7.91% | 4.97% | 5.20% |
TXG 10x Genomics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
SBRA vs. TXG - Drawdown Comparison
The maximum SBRA drawdown since its inception was -74.93%, smaller than the maximum TXG drawdown of -92.66%. Use the drawdown chart below to compare losses from any high point for SBRA and TXG. For additional features, visit the drawdowns tool.
Volatility
SBRA vs. TXG - Volatility Comparison
The current volatility for Sabra Health Care REIT, Inc. (SBRA) is 7.76%, while 10x Genomics, Inc. (TXG) has a volatility of 12.80%. This indicates that SBRA experiences smaller price fluctuations and is considered to be less risky than TXG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SBRA vs. TXG - Financials Comparison
This section allows you to compare key financial metrics between Sabra Health Care REIT, Inc. and 10x Genomics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities